Carta Healthcare secured $18.25 M in Series B1 funding led by UPMC Enterprises and other strategic health system investors to expand its AI-powered clinical data abstraction and analytics platform, accelerate growth especially in life sciences, and scale solutions that improve data insights and care delivery.
Carta Healthcare secured $18.25M in Series B1 funding led by UPMC Enterprises with strategic health system investors to expand its AI-powered clinical data abstraction and analytics platform, accelerate growth especially in life sciences, and streamline data insights for care and research.
The article stresses that better data sharing and collaboration speeds bench-to-bedside discoveries by streamlining clinical trial recruitment and data management using AI. Carta Healthcare’s AI clinical data platform helps accelerate research, extract real-world insights, and match patients to trials, supporting this collaborative translational effort.
At HIMSS25, AI’s practical use in healthcare was a central theme. Vendors, including Carta Healthcare, emphasized real-world AI applications that reduce admin burden, improve workflows, and support value-based care, showing where healthcare tech is moving beyond hype into measurable impact.
The article highlights AI’s role in improving patient outcomes and streamlining healthcare operations, including reducing admin burden and enhancing clinical decision support. Carta Healthcare’s AI clinical data tools fit this trend by improving data accuracy, speeding abstraction, and freeing clinicians for patient care.
HITConsultant highlights key HIMSS25 trends like AI, interoperability, and predictive analytics driving value-based care. Executives stressed the need for high-quality structured data for effective AI — aligning with Carta Healthcare’s AI clinical data abstraction platform that fuels better insights and workflows.
The article discusses whether AI can replace clinical data abstractors, noting Carta Healthcare’s survey showing most abstractors believe AI reduces workload but still needs human oversight for quality. Carta’s hybrid AI-plus-expert approach reflects this balance.
A Carta Healthcare survey found most clinical data abstractors believe AI can save time, reduce effort and cut costs, but many lack access to AI tools at work and worry about data quality without human oversight. Carta’s platform blends AI with expert review to address these gaps.
Investment led by UPMC Enterprises, with participation from MemorialCare Innovation Fund, Rex Health Ventures, Tampa General Hospital Ventures, Memorial Hermann Health System, Frist Cressey Ventures, Storm Ventures, Paramark Ventures, CU Healthcare Innovation Fund, and Mass General Brigham Ventures
Results reveal familiarity with potential workflow benefits, although concerns about human oversight and quality remain
Acknowledged for its clinical data abstraction platform, Carta Healthcare showcases its leadership in shaping the future.
Carta Healthcare won a Diamond Award for AI & Automation Leadership at the first annual Pinnacle Awards for Business, recognizing its AI-powered clinical data abstraction platform for innovation and impact in healthcare data management.
Prestigious recognition highlights leaders in current and next-generation innovations and technologies.
New survey results reveal that clinical data abstractors view clinical registries as indispensable for evaluating care quality and population health outcomes.
Three out of five clinical data abstractors are neutral to very dissatisfied in their positions, with nearly as many attributing too many time-consuming, manual tasks as the top contributors to their dissatisfaction.
A majority of healthcare workers (76.9%) think that emerging tech like AI could be useful to help combat the shortage of healthcare workers.
Stay informed with the latest updates and expert insights. Explore breaking news and industry trends all in one place. Contact us for more!
2443 Fillmore St #380-17156 San Francisco, CA 94115
